Your browser doesn't support javascript.
loading
Proton Pump Inhibitors and Kidney Disease: An Intertwined Relationship.
Rong, Heidy; Chen, Stanley; Liu, Antong; Nguyen, Timothy.
Afiliação
  • Rong H; Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, NY.
  • Chen S; Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, NY.
  • Liu A; Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, NY.
  • Nguyen T; Professor of Pharmacy Practice and Clinical Pharmacotherapy Specialist, Nephrology and Dialysis, Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, NY.
Nephrol Nurs J ; 50(5): 415-419, 2023.
Article em En | MEDLINE | ID: mdl-37983550
ABSTRACT
Many patients with kidney disease are taking proton pump inhibitors (PPIs) for various gastrointestinal conditions. There are concerns about inappropriate usage of PPIs with unknown consequences, which include worsening kidney function. PPI use has been associated with kidney damage; however, a clear etiology of the association is uncertain. Potential mechanisms theorized for PPI-induced kidney damage include hypersensitivity, hypomagnesemia, gut microbiota alterations, uremic toxins, gastrointestinal hormones, and oxidative stress. Patients with kidney disease who are taking long-term PPI therapy require close monitoring for any signs and symptoms of kidney disease. Improper use of PPIs should also be reassessed and de-prescribed as indicated.
Assuntos
Palavras-chave
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores da Bomba de Prótons / Nefropatias Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores da Bomba de Prótons / Nefropatias Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article